IV Medications by

BNF

2025-07-18 09:06:34 UTC

It is good practice to examine intravenous infusions from time to time while they are running.

2025-07-18 09:07:28 UTC

Certain injections must be protected from light during continuous infusion to minimise oxidation, e.g. dacarbazine and sodium nitroprusside.

24hrs v 72hrs

2025-07-18 09:07:38 UTC

The BNF states: Strict asepsis should be maintained throughout and in general the giving set should not be used for more than 24 hours (for drug admixtures).

However, in Oncology they have a maximum of 72hrs for the maximum amount of time they can use the same line.

adding potassium to IV fluids must be done with extreme care, if not mixed thoroughly (by inverting the bag at least 5–20 times), it can settle and cause a dangerous potassium bolus potentially leading to cardiac arrest

2025-07-18 09:07:50 UTC

BNF

2025-07-18 09:08:30 UTC

The BNF gives information about preparations given by three methods:

continuous infusion;
intermittent infusion;
addition via the drip tubing.

Certain injections must be protected from light during continuous infusion to minimise oxidation, e.g. dacarbazine and sodium nitroprusside.

2025-07-18 09:08:38 UTC

Bactericides such as chlorocresol 0.1% or phenylmercuric nitrate 0.001% are present in some injection solutions.

2025-07-18 09:09:50 UTC

A number of preparations undergo significant loss of potency when added singly or in combination to large volume infusions.

2025-07-18 09:10:36 UTC

It is good practice to examine intravenous infusions from time to time while they are running. If cloudiness, crystallisation, change of colour, or any other sign of interaction or contamination is observed the infusion should be discontinued.

When is this ever done unless the box is alarming.......

2025-07-18 09:11:34 UTC

drugs can be given intermittently 100ml over 30 mins if the drug is unstable over longer periods

It is good practice to examine intravenous infusions from time to time while they are running. If cloudiness, crystallisation, change of colour, or any other sign of interaction or contamination is observed the infusion should be discontinued.

2025-07-18 09:11:42 UTC